InsidersTradesSigma
Follow the SCL사이언스 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, SCL사이언스 has published 3 insider filings. Market capitalisation: €55.8bn. The latest transaction was filed on 18 March 2026 (Other). Among the most active insiders: SCL사이언스. All data is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,292 of 29,063 companies
17.3
score / 100
Value18
Quality17
FCF yld-8.3%
Earn yld-7.1%
EV/EBITDA·
ROE-13%
Gross mgn19%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 March 2026
关于 SCL사이언스
SCL사이언스 是一家在 XKRX 市场上市的医疗保健和制药公司。它专注于为医疗领域开发创新解决方案。